The OncoAlert Network is pleased to present its collective expert view on the PROSPECT clinical trial for rectal cancer presented at #ASCO23 As a leading source of timely and reliable information in oncology, we are honored to contribute our consensus opinion on this study. In line with our commitment, and in agreement with the statements from our Partners at @ASTRO_org and our colleagues at @ESTRO_RT
Here is our official stance on the PROSPECT trial as drafted by our @OncoAlert RadiationTherapy& GI Oncology faculty, inclusive of Patient Advocates.
The OncoAlert Network acknowledges the influence of the PROSPECT trial on the management of #RectalCancer. Given the intricate nature of this disease, our esteemed panel of experts has diligently examined the existing data and is eager to present the following discerning observations:
.@ASTRO_org
.
Here is our official stance on the PROSPECT trial as drafted by our @OncoAlert RadiationTherapy& GI Oncology faculty, inclusive of Patient Advocates.
The OncoAlert Network acknowledges the influence of the PROSPECT trial on the management of #RectalCancer. Given the intricate nature of this disease, our esteemed panel of experts has diligently examined the existing data and is eager to present the following discerning observations:
.@ASTRO_org
.
|
|
